1 “...The current question is whether early mobilization is more beneficial for patients than bed rest...”

2 “...The current question is whether early mobilization is more beneficial for patients than bed rest...”

3 “... of dMMR status on CRC outcomes in the current era of oxaliplatin- and irinotecan-based chemotherapy...”

4 “... of dMMR status on CRC outcomes in the current era of oxaliplatin- and irinotecan-based chemotherapy...”

5 “... of tumour dMMR status on CRC outcomes in the current era of oxaliplatin- and irinotecan-based chemotherapy...”

6 “... of tumour dMMR status on CRC outcomes in the current era of oxaliplatin- and irinotecan-based chemotherapy...”

7 “... or are currently under regulatory review (apixaban) for the prevention of stroke and systemic embolism (SE...”

8 “... or are currently under regulatory review (apixaban) for the prevention of stroke and systemic embolism (SE...”

9 “... or are currently under regulatory review (apixaban) for the prevention of stroke and systemic embolism (SE...”

10 “... or are currently under regulatory review (apixaban) for the prevention of stroke and systemic embolism (SE...”

11 “.... Though it is promising and increasingly being used, there are currently no set recommendations...”

12 “.... Though it is promising and increasingly being used, there are currently no set recommendations...”

13 “... questions from that report. The aim of the current report is to summarize and critically appraise...”

14 “... questions from that report. The aim of the current report is to summarize and critically appraise...”

15 “... the current clinical evidence and evidence-based guideline recommendations for this procedure...”